Engoren Milo, Arslanian-Engoren Cynthia
Department of Anesthesiology, School of Medicine, University of Michigan, Ann Arbor, MI, United States.
School of Nursing, University of Michigan, Ann Arbor, MI, United States.
Heart Lung. 2022 Mar-Apr;52:37-41. doi: 10.1016/j.hrtlng.2021.11.001. Epub 2021 Nov 24.
Studies of sepsis evaluating sex- and race-related disparities in treatment and outcome have been limited by using administrative databases, which may not adequately capture sepsis diagnosis, used limited number and types of races, or not included both sex and race in the analyses.
To determine if patients of different races and sexes with sepsis have different mortality, receipt of mechanical ventilation or renal replacement therapy, or time to antibiotics?
We retrospectively analyzed clinical data from 34,999 patients with sepsis, defined by Sepsis-3 criteria, using logistic regression and linear regression.
After adjustments for confounders, Asian females had the lowest adjusted 90-day mortality (OR=0.656, 95% CI=0.385-1.118, p<0.001 compared to White males). Similarly, compared to White males, African-American males had a lower adjusted mortality (OR=0.790, 95% CI=0.648-0.963, p = 0.019), while Asian males (OR=1.185, 95% CI=0. 828-1.696, p = 0.354) and both African-American (OR=0.972, 95% CI=0.800-1.182, p = 0.779) and Caucasian (OR=1.054, 95% CI=0.960-1.158, p = 0.270) females had similar mortality. Both male and female patients with Other/unknown race had higher mortality (OR=1.776, 95% CI=1.395-2.261, p<0.001 and OR=1.658, 95% CI=1.359-2.021, p<0.001), respectively. In the secondary analyses for new-onset mechanical ventilation and new-onset renal replacement therapy post-sepsis, we found no association between any of the race-sex groups and receipt of these therapies.
We found that Asian females had the lowest adjusted 90-day mortality for patients with sepsis. Understanding the reasons for disparities in outcome after sepsis may improve care and outcomes in diverse populations.
评估脓毒症治疗及预后中性别和种族差异的研究因使用行政数据库而受到限制,这些数据库可能无法充分捕捉脓毒症诊断情况,使用的种族数量和类型有限,或者在分析中未同时纳入性别和种族因素。
确定不同种族和性别的脓毒症患者在死亡率、接受机械通气或肾脏替代治疗情况,以及使用抗生素的时间方面是否存在差异?
我们采用逻辑回归和线性回归方法,对34999例符合脓毒症3标准定义的脓毒症患者的临床数据进行回顾性分析。
在对混杂因素进行调整后,亚洲女性的校正90天死亡率最低(与白人男性相比,OR = 0.656,95%CI = 0.385 - 1.118,p < 0.001)。同样地,与白人男性相比,非裔美国男性的校正死亡率较低(OR = 0.790,95%CI = 0.648 - 0.963,p = 0.019),而亚洲男性(OR = 1.185,95%CI = 0.828 - 1.696,p = 0.354)以及非裔美国女性(OR = 0.972,95%CI = 0.800 - 1.182,p = 0.779)和白人女性(OR = 1.054,95%CI = 0.960 - 1.158,p = 0.270)的死亡率相似。其他/种族不明的男性和女性患者死亡率均较高(分别为OR = 1.776,95%CI = 1.395 - 2.261,p < 0.001和OR = 1.658,95%CI = 1.359 - 2.021,p < 0.001)。在对脓毒症后新发机械通气和新发肾脏替代治疗的二次分析中,我们发现任何种族 - 性别组与接受这些治疗之间均无关联。
我们发现亚洲女性是脓毒症患者中校正90天死亡率最低的群体。了解脓毒症后预后差异的原因可能会改善不同人群的治疗和预后情况。